Article 03 Jul 2024 Mifepristone Litigation Update: Supreme Court Ruling On Standing Grounds Preserves The Status Quo Of FDA Regulation Of Mifepristone United States Litigation
Article 21 Nov 2019 A New Dawn For Challenges To FDA Actions? Kisor And The Tenuous Vitality Of Administrative Deference United States Healthcare
Article 28 Dec 2017 The Latest FDA Move To Limit Digital Health Software Regs United States Healthcare